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Aim: To determine which simulated-use test soils met the worst-case organic levels and
viscosity of clinical secretions, and had the best adhesive characteristics.
Methods: Levels of protein, carbohydrate and haemoglobin, and vibrational viscosity of
clinical endoscope secretions were compared with test soils including ATS, ATS2015,
Edinburgh, Edinburgh-M (modified), Miles, 10% serum and coagulated whole blood. ASTM
D3359 was used for adhesion testing. Cleaning of a single-channel flexible intubation
endoscope was tested after simulated use.
Results: The worst-case levels of protein, carbohydrate and haemoglobin, and viscosity of
clinical material were 219,828 mg/mL, 9296 mg/mL, 9562 mg/mL and 6 cP, respectively.
Whole blood, ATS2015 and Edinburgh-M were pipettable with viscosities of 3.4 cP, 9.0 cP
and 11.9 cP, respectively. ATS2015 and Edinburgh-M best matched the worst-case clinical
parameters, but ATS had the best adhesion with 7% removal (36.7% for Edinburgh-M).
Edinburgh-M and ATS2015 showed similar soiling and removal characteristics from the
surface and lumen of a flexible intubation endoscope.
Conclusions: Of the test soils evaluated, ATS2015 and Edinburgh-M were found to be good
choices for the simulated use of endoscopes, as their composition and viscosity most
closely matched worst-case clinical material.
ª 2016 The Authors. Published by Elsevier Ltd
on behalf of the Healthcare Infection Society. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Reprocessing of re-usable medical devices requires effec-
tive cleaning followed by appropriate disinfection or sterili-
zation. Regulatory bodies in most countries require
manufacturers to validate reprocessing protocols for re-usablece Research Centre, 351
2H 2A6. Tel.: þ1 204 235
.
Elsevier Ltd on behalf of the
ivecommons.org/licenses/by-medical devices. Previously, the focus was on validation of the
disinfection/sterilization process, but the need for validation
of cleaning has been recognized recently. Recent outbreaks of
multi-drug-resistant Enterobacteriaceae and Pseudomonas
aeruginosa, often linked to improper cleaning of flexible en-
doscopes, emphasize the need for manufacturers to validate
their instructions for cleaning medical devices.1e4 The recently
released Food and Drug Administration (FDA) guideline requires
manufacturers to validate their cleaning instructions in addi-
tion to validation of their disinfection/sterilization in-
structions.5 As part of cleaning validation, manufacturers mustHealthcare Infection Society. This is an open access article
nc-nd/4.0/).
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the device is soiled with an organic test soil, is a critical part of
the cleaning validation process.5 A wide range of test soils have
been used, such as 10% serum, coagulated blood, ATS, Hucker’s
soil, Miles soil, Edinburgh soil etc.6,7 The FDA guideline rec-
ommends that the test soil used for simulated-use testing
should represent worst-case conditions, and reflect the type of
soil to which the device would be exposed during clinical use.5
However, few clinical data have been published to help guide
the selection of an appropriate test soil. Although coagulated
blood is a logical test soil for surgical instruments, the formu-
lations used for other medical devices (e.g. rigid cystoscopes,
flexible endoscopes etc.) have been defined less clearly. Many
of the test soils in current use represent empiric formulations
designed to contain blood constituents and to be difficult to
remove. Few reports have been published regarding how the
characteristics of various test soils relate to the patient se-
cretions that medical devices are exposed to during clinical
use.
The aim of this study was to compare a variety of simulated-
use test soils with relevant clinical samples from endoscopes
with respect to organic composition, viscosity and surface
adhesiveness, and subsequently to compare the optimal test
soils by testing the cleaning of a flexible endoscope following
simulated use.Materials and methods
Test soils evaluated
The blood test soil using heparinized sheep blood (Cedar-
Lane, Burlington, ON, USA) was coagulated by adding 1mg
protamine sulphate (Sigma, St. Louis, MO, USA) per 1 mL of
either whole or 10% heparinized sheep blood. The Edinburgh
test soil was prepared as described in ISO/TS 15883-5 Annex N,6
and consisted of 100 mL egg yolk, 10 mL defibrinated sheep
blood (CedarLane) and 2 g Hog mucin (Sigma). The Edinburgh-M
(modified) soil consisted of 100mL egg yolk, 100mL defibrin-
ated sheep blood (CedarLane) and 2 g Hog mucin. Miles soil
consisted of 1 mL sheep blood, 6 g dry milk powder, 10 mL fetal
calf serum (Life Technologies Inc, Burlingon, ON, USA) and 1mL
saline (0.9% NaCl). ATS was prepared fresh as per proprietary
formulation covered by USA Patent# 6,447,990. The lyophilized
ATS2015 version was provided by Healthmark Industries Com-
pany Inc. (Fraser, MI, USA), and contained a physiological salt
base containing mucin, insoluble cellulose fibre, and recon-
stituted dried egg yolk with the subsequent addition of 20%
sterile sheep blood (CedarLane). The ATS2015 formulation is a
revised version of the original ATS formulation. A unique
component of ATS2015 is the presence of insoluble cellulose
(which is found in patient material such as faeces); this is not
present in any of the other currently described test soils.6Clinical samples
Patient secretions were suctioned through duodenoscopes
or colonoscopes during clinical procedures (these secretions
would normally have been discarded and there were no patient
identifiers). To ensure that the suctioned secretions were not
diluted, the suction canister was removed at the end of the
clinical procedure, prior to bedside flushing of the channels. Itwas not possible to obtain sufficient suctioned material from
the gastroscopes used for clinical procedures. Other clinical
samples used for compositional and viscosity testing included
urine (samples would normally have been discarded after
diagnostic testing, with all patient identifiers removed) and
faeces from healthy adult volunteers.
Viscosity testing
Viscosity was measured using a HAAKE rotational viscotester
1 (Thermo Electron GmbH, Karlsruhe, Germany) or a Viscolite
700 vibrational viscometer (Hydramotion Ltd, Malton, UK).
Unless specified otherwise, viscosity was measured at 25C. To
ensure that the viscometers were functioning properly, 5 cP
(Lot# 13101), 10 cP (Lot # 13101) and 50 cP (Lot # 11101c) vis-
cosity standards (Cannon Instrument Co., State College, PA,
USA) were used. The minimum volume to test rotational vis-
cosity (RV) was 100 mL, whereas 20e25mL of sample was
needed to test vibrational viscosity (VV).
Quantitative organic marker assays
The QuantiPro BCA assay kit (Sigma), which includes a
bovine serum albumin protein standard and is a quantitative
assay based on bicinchoninic acid, was used to quantitate
protein. The TMB (3,30,5,50 tetramethylbenzadine) liquid sub-
strate system for enzyme-linked immunosorbent assays (Sigma)
was used for haemoglobin quantitation, in conjunction with an
80mg/dL cyanmethemoglobin standard (Stanbio Laboratory,
Boerne, TX, USA). The haemoglobin and protein assays were
performed in accordance with the manufacturers’ instructions,
and had limits of detection of 5 mg/mL and 0.5 mg/mL,
respectively. Carbohydrate was assessed using the method
described by Lui et al.,8 and the limit of detection for this assay
was 10 mg/mL.
ASTM D3359 adhesion test
The adhesion test followed the directions for the ASTM
D3359 methodology.9 However, instead of using a visual score,
the percentage weight of applied dried test soil that remained
after adhesion testing was determined.
Simulated-use testing for cleaning of endoscopes
A comparison of endoscope soiling and cleaning character-
istics of optimal test soils was performed using three KARL
STORZ Endovision Inc. (Charlton, MA, USA) single-channel
flexible intubation endoscopes (Model 11304BC1). The manu-
facturer’s instructions for use were followed for manual
cleaning of the scope using the worst-case conditions (i.e.
lowest concentration of detergent in the range recommended,
fewest passes of the channel brush etc). Enzol (Advanced
Sterilization Products, Irvine, CA, USA) was used as the clean-
ing detergent. The channel was perfused with test soil con-
taining w108 colony-forming units/mL of Pseudomonas
aeruginosa and Enterococcus faecalis, and excess soil was
flushed from the channel. The drying was expedited by flushing
additional air through the channel. Two surface sites (insertion
tube and control head) were inoculated with 50 mL of the same
test soil. The inoculated endoscopes were then held at room
temperature for 2 h to mimic routine transit times in clinical
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rounds of extraction of the soiled intubation endoscopes. The
markers used were protein, haemoglobin and viable count.Results
Ideally, viscosity of a test soil should reflect what the
medical device is exposed to during clinical use. Table I shows
VV and RV measured on various human secretions and body
fluids with sufficient volume to take both measurements. As
the clinical endoscope sample volumes were insufficient to
measure using RV, they were measured using VV alone. The
highest viscosity (VV of 6 cP) was detected in patient material
suctioned through a colonoscope. The viscosities for ATS and
ATS2015 (Table II) were very similar to that of the worst-case
(i.e. highest level in the range) patient material aspirated
through flexible endoscope channels. The viscosities of Edin-
burgh, Edinburgh-M and Miles soils weremuch higher, and those
for anticoagulated blood, serum and urine were much lower,
than the worst-case viscosity for patient material suctioned
through gastrointestinal flexible endoscopes. Table I also
compares RV with VV for commercial silicone standards.
The organic composition of the patient secretions and body
fluids included determination of the protein, carbohydrate and
haemoglobin levels (Table I). The highest protein
(219,828.1 mg/mL) and carbohydrate (9296.5 mg/mL) levels
were found in colonoscope-suctioned secretions, whereas the
highest haemoglobin level (2300 mg/mL) was found in
duodenoscope-suctioned secretions. Table I also provides data
on the organic composition of a variety of simulated-use test
soils. All of the test soils evaluated (excluding 10% blood and 10%
serum) had protein, carbohydrate and haemoglobin levels that
were comparable to the average for suctioned clinical secre-
tions. Although ATS2015, Edinburgh, Edinburgh-M and Miles test
soils all exceeded the worst-case levels of carbohydrate and
haemoglobin, none of the evaluated test soils reached the
highest range of protein detected in secretions suctioned
through colonoscopes (Table II). It should be noted that only one
of the nine colonoscope samples had protein >200,000 mg/mL,
one of the nine samples had protein ofw20,000 mg/mL, and the
remainder had protein <10,000 mg/mL.
Table I provides the results of ASTM D3359 adhesion testing
of a range of test soils.9 Coagulated whole blood and Miles soil
dried on to the stainless steel carrier were the least adhesive
(>90% removal), whereas ATS and ATS2015 demonstrated the
best adhesive characteristics (16% and 7% removal,
respectively).
For a functional comparison, the two optimal endoscope
test soils (Edinburgh-M and ATS2015) were used to soil the
lumen and two surface sites on the exterior of a single-channel
flexible intubation endoscope. The harvesting efficacy and
impact of cleaning for flexible intubation endoscopes soiled
with ATS2015 and Edinburgh-M soils are shown in Table II.
Overall, both test soils showed similar extraction efficacy, and
residual protein, carbohydrate and haemoglobin levels after
cleaning.Discussion
Many issues are related to optimizing the soils used for
simulated-use testing. However, this study focused on threecharacteristics: (1) viscosity of the test soil; (2) adhesion of the
test soil; and (3) organic composition of the test soil. Current
guidelines provide recipes or general descriptions for various
test soils, but there are no standardized requirements for vis-
cosity, adhesion or quantitation of organic composition.5e7
Although the present authors previously published worst-case
soiling data by extracting patient-used endoscope channels,10
to the authors’ knowledge, this is the first study to provide
data on viscosity and composition of clinical material suctioned
through endoscopes.
For test soils containing biological materials (e.g. blood,
serum, egg yolk etc.), the cP values obtained for RV differed
from those obtained by VV (Table I). As highlighted by the
manufacturer of the VV apparatus, variable viscosity in bio-
logical materials may be due to shear factors being different
from homogenous materials (e.g. blood vs silicone viscosity
standards). This analysis supports VV as it allows assessment of
clinical samples with volumes that are too small to be tested
using RV. A minimum VV of 6 cP would be appropriate for
simulated-use test soils, as this was the highest viscosity of
patient secretions passing through endoscope channels during
a clinical procedure. Highly viscous test soils with VV of 15 cP or
higher cannot reliably perfuse lumens with narrow diameters
(e.g. Miles and Edinburgh soils).
ATS2015, Edinburgh, Edinburgh-M and Miles test soils all met
the worst-case levels for carbohydrate, haemoglobin and vis-
cosity, but none of them met the worst-case protein level
(w200,000 mg/mL) in clinical material. However, it should be
noted that only one of nine endoscope samples had
>200,000 mg/mL protein, and the majority had protein
<10,000 mg/mL.
Adhesiveness after drying is another important character-
istic, as the more adhesive a test soil, the more difficult it is to
wash off a medical device. There is much debate but few
clinical data regarding how adhesive test soils need to be to
mimic worst-case soiling of medical devices. Herve and Keevil11
used Edinburgh soil to assess endoscope channels, although it is
unclear how the channels were perfused. Their data showed
rapid adhesion of protein to air/water and suction channel
surfaces; however, no other test soils were evaluated and they
did not use quantitative protein measurements. The present
study is the first to demonstrate that as the levels of protein
and carbohydrate increase, the adhesive characteristics of the
test soil decrease. Of the soils tested, Miles soil and coagulated
sheep blood had the least adhesive characteristics when dried
on to a stainless steel surface, whereas ATS2015 had the
highest adhesion. Based on these data, it is recommended that
<40% removal of the test soil represents a reasonable adhesion
challenge for the validation of endoscope cleaning. A limitation
of this study was that stainless steel was the only test surface
evaluated for adhesion testing, and clinical material was not
tested. Additional research is needed to determine the adhe-
siveness of test soils and clinical secretions on other materials
used in medical devices (e.g. neoprene, PTFE).
Coagulation of blood on and within channels and recesses of
re-usable medical devices is a parameter of concern as it can
be very difficult to remove during cleaning. This study showed
that once fully coagulated and dried, blood flakes off and is not
very adhesive. As such, the key concern for blood would be
coagulation and occlusion within narrow lumens. In gastroin-
testinal endoscopy procedures, there is frequent water flushing
to keep the gut mucosa and endoscope lens clear of blood and
Table I
Composition, adhesion and viscosity of various patient secretions and test soils
Test soil or sample Protein (mg/mL) Haemoglobin (mg/mL) Carbohydrate (mg/mL) ASTMa adhesion test %
inoculated soil removed
Average rotational
viscosity (cP)
Average vibrational
viscosity (cP)
Patient secretions aspirated through endoscope suction channelb
Colonoscope
Suction canister sample
N¼ 9 samples
34,419.7
(1866.3e219,828.1)
103.8
(13.3e497.4)
3420.6
(725.1e9296.5)
ND ND 3.2 (1.3e6.0), 6 samples
Duodenoscope
Suction canister sample
N¼ 8 samples
9067.4
(4503.8e17,965.8)
2285.4
(52.8e9562.2)
1288.0
(846.1e1717.3)
ND ND 1.2 (0.9e1.7), 4 samples
Healthy normal stool
N¼ 3 samples
108,130.5
(76,333.3e206,946.8
1260.6
(138.2e2865.7)
22,823.7
(15,257.6e33,061.3)
ND ND 2.0c (1.5e2.9), 3 samples
Urine
N¼ 10 samples
ND ND ND ND ND 0.88 (0.8e1.0), 10 samples
Simulated-use test soils
ATSd (freshly prepared) 23,161.50 7411.07 7146.86 16 62 3.7
ATS2015e (commercial version) 59,076.89 57,706.94 20,515.80 7 ND 9.0
Edinburgh soil 104,564.64 13,351.16 9155.84 46.9 375 73.4
Edinburgh-M soil 125,032.63 90,075.01 5998.08 36.7 ND 11.87
Miles soil 171,460.62 13,176.41 227,071.15 95.1 ND 23.2
Sheep blood (heparinized) 99,544.24 9251.40 2345.12 96.0 (coagulated) 6.58 (20C) 3.4
10% sheep blood (heparinized) 14,726.25 964.29 104.80 23.2 (coagulated) ND 0.8
10% bovine (calf) serum 6419.23 75.27 168.58 8.6 2.18 0.7
Viscosity standards
Standard RT5 (5 cP) N/A N/A N/A N/A 6.8 4.3
Standard RT50 (50 cP) N/A N/A N/A N/A 65 46.1
Standard RT100 (100 cP) N/A N/A N/A N/A 116 95.1
ND, not done; N/A, not applicable.
a ASTM D3359 adhesion test results represent the % of soil inoculated (mg) that was removed by the test (average of triplicate testing reported).
b Only vibrational viscosity could be performed due to smaller volume of material available from each patient procedure.
c Viscosity testing performed on stool that was diluted 1:4 as direct stool was too thick to be transferred into tube for testing.
d Freshly prepared ATS was the test soil used in all publications by MJ Alfa up to 2015.
e See ‘Materials and methods’ for manufacturer information.
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Table II
Functional comparison of ATS2015 and Edinburgh-M test soils for the validation of cleaning of a flexible intubation endoscope
ATS2015 Edinburgh-M soil
Average mg/cm2 (SD)a
Protein Haemoglobin Protein Haemoglobin
Harvesting efficiency
Channel (L1) 89.5% 89.6% 79.5% 84.2%
Surface 1 (eyepiece) 93.3% 93.2% 95.8% 98.7%
Surface 2 (insertion tube) 84.6% 91.2% 84.9% 84.2%
Positive endoscope controls: soiled but uncleaned
Channel (L1) 919.84 (217.62) 834.62 (107.46) 2137.01 (406.42) 1261.37 (239.13)
Surface 1 (eyepiece) 418.09 (206.87) 167.89 (26.36) 902.17 (434.42) 525.09 (74.90)
Surface 2 (insertion tube) 484.34 (121.46) 498.34 (26.70) 653.18 (396.39) 357.88 (194.57)
Negative endoscope controls: fully reprocessed endoscope
Channel (L1) 0.94 (0.86) < LD 0.94 (0.86) < LD
Surface 1 (eyepiece) 2.61 (1.33) < LD 2.61 (1.33) < LD
Surface 2 (insertion tube ) 0.91 (0.42) < LD 0.91 (0.42) < LD
Endoscope cleaned fully in accordance with the manufacturer’s instructions
Channel (L1) 0.05 (0.08) < LD < LD < LD
Surface 1 (eyepiece) 0.55 (0.29) < LD 0.58 (0.26) < LD
Surface 2 (insertion tube ) 0.22 (0.10) < LD 0.24 (0.05) < LD
a Results represent the average results from three replicate scopes and the standard deviation (SD). LD, limit of detection.
M.J. Alfa, N. Olson / Journal of Hospital Infection 93 (2016) 83e88 87other secretions. In gastrointestinal endoscopy, it would be
unlikely that coagulated blood would occlude the endoscope
channel(s), as frequent flushing would cause dilution and the
coagulation cascade would be unable to produce clotting.
However, more clinical data are needed on emergency endos-
copy procedures for gastrointestinal bleeds to establish blood
soiling levels within endoscope channels.
Despite not meeting the worst-case protein levels from
gastrointestinal secretions, both ATS2015 and Edinburgh-M
soils provided adequate positive control soiling for endoscope
channels and surfaces, with protein and haemoglobin levels
well above the worst-case levels of 115 mg/cm2 and 85 mg/cm2,
respectively, reported previously.10 Furthermore, cleaning of
both test soils in accordance with the manufacturers’ in-
structions removed protein and haemoglobin adequately to
achieve the target benchmarks of <6.4 mg/cm2 and <2.2 mg/
cm2, respectively.10,12 The harvesting efficiency from inocu-
lated surface and channel sites were equivalent for both
ATS2015 and Edinburgh-M soils (both >80%).
The objective of this study was to determine if the
composition, viscosity and adhesiveness of the evaluated test
soils were reflective of what flexible endoscopes were exposed
to in clinical use. Based on the findings, test soils used for
flexible endoscope testing should have VV of 6 cP but <15 cP;
an adhesive factor showing <40% of soil removed by the ASTM
D3359 adhesion test;9 and protein, haemoglobin and carbo-
hydrate levels similar to worst-case fluids suctioned through
patient-used endoscopes. Based on these criteria, the optimal
test soils (of those tested) to validate the cleaning of flexible
endoscopes were ATS2015 and Edinburgh-M soils. The key
differences between the test soils were:
e ATS2015 was easier to perfuse through small lumens, had
better adhesive properties when dried, and contained
insoluble cellulose (no other test soil contains an insoluble
component).e Edinburgh (original formulation) and Miles soils were too
viscous to flush reliably through small lumens, and their
adhesive properties were inadequate.
e ATS meets average but not worst-case organic levels found
in patient material, but, when used to perfuse endoscope
channels, it does result in a protein level higher than the
worst-case soil levels reported in patient-used endoscope
channels.10,13
e Test soils such as 10% serum and 10% coagulated sheep
blood do not have protein, carbohydrate or haemoglobin
levels that adequately reflect either average or worst-case
levels in patient secretions from flexible gastroscope
channels.
A limitation of this study is that only a limited number of test
soils were evaluated. Further studies are needed to compare
other test soils in ISO/TS 15883-5 (Annex E,F,I,L,R)6 that are
intended for testing of flexible endoscopes. Although the
channel diameter in the single-channel flexible endoscopes
used in this evaluation was similar to that of gastrointestinal
endoscopes, it is a limitation of this study that only one type of
scope was used. As there may be design and composition dif-
ferences between different types of flexible endoscopes and
different manufacturers, it would be valuable for future
studies to test ATS2015 and Edinburgh-M soils in a wider range
of endoscope types.
In summary, ATS2015 and Edinburgh-M soils are both
appropriate for validation of the cleaning of flexible endo-
scopes as their adhesive characteristics are good, and their
viscosity and composition are similar to the worst-case patient
secretions to which flexible endoscopes would be exposed.
Both test soils had protein and haemoglobin levels above the
worst-case clinical levels for endoscope channels and exterior
surfaces, thereby allowing reliable tracking of the removal of
these markers after the cleaning process. The data from this
study provide scientific rationale based on clinical data for the
M.J. Alfa, N. Olson / Journal of Hospital Infection 93 (2016) 83e8888composition and viscosity of test soils, as well as an approach to
characterize the adhesiveness of test soils. This data extends
our knowledge of clinically relevant soiling characteristics, so
that standardized parameters for test soils used for the vali-
dation of cleaning can be established in the future. This will be
helpful information for guidance documents that outline
manufacturers’ requirements for the validation of cleaning of
re-usable medical devices from various countries.5,6,14
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